Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324545 · ClinicalTrials.gov registry record · Phase 3
Cardiovascular Outcomes Of Diet Counseling
A Phase 3 study of Obesity and Coronary Artery Disease, sponsored by The Camelot Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT00324545 is a Phase 3 study of Obesity and Coronary Artery Disease that has completed, run by The Camelot Foundation. The registered enrollment target is 120 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00324545, a Phase 3 study of Obesity and Coronary Artery Disease, has completed, sponsored by The Camelot Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
(1) What effect does behavioral counseling for vegan, for low to moderate fat, and for lowered carbohydrate diets have on coronary blood flow? (2) What are the effects of different diet protocols when caloric intake and exercise are equalized? (3) Do people, so counseled, maintain their modified behaviors after they have completed their diet program? (4) How does targeting different diets affect secondary indices associated with heart disease such as weight, lipid, inflammatory, and thrombotic factors?
Conditions Studied
Interventions
- BEHAVIORAL Medium-intensity Minimally-directive Counseling
Study Locations (2)
Illinois
- Keith Block - Chicago
Nebraska
- Richard M. Fleming, MD - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2000-01-01 |
| Est. Completion | 2002-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00324545
The ClinicalTrials.gov registry entry for NCT00324545 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The listed sponsor is The Camelot Foundation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Medium-intensity Minimally-directive Counseling is the first listed.
NCT00324545 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Nebraska.
Frequently Asked Questions
What is clinical trial NCT00324545 about?
NCT00324545 is a clinical study titled "Cardiovascular Outcomes Of Diet Counseling". (1) What effect does behavioral counseling for vegan, for low to moderate fat, and for lowered carbohydrate diets have on coronary blood flow? (2) What are the effects of different diet protocols when caloric intake and exercise are equalized? (3) Do people, so counseled, maintain their modified beh...
What is the current status of trial NCT00324545?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2000-01-01. Estimated completion is 2002-12-31.
What conditions does trial NCT00324545 study?
This clinical trial studies the following conditions: Obesity, Coronary Artery Disease.
What interventions are being tested in trial NCT00324545?
The interventions under investigation include: Medium-intensity Minimally-directive Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00324545?
This trial is sponsored by The Camelot Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00324545 being conducted?
This trial has 2 study locations across Illinois, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RECRUITING · Phase 3
-
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
RECRUITING · Phase 3
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
RECRUITING · Phase 3
-
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.